Heather Mott
Psychiatric/Mental Health · Jeffersonville, INNPI 1568707370
Payments from drug & device makers
Across 153 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neuronetics, Inc.$993
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$404
- Otsuka America Pharmaceutical, Inc.$170
- Teva Pharmaceuticals USA, Inc.$90
- Lundbeck LLC$64
- plus $363 from 10 others
What the payments were for
- Travel & lodging$44714%
- Food & beverage$2,70486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$747
- VRAYLAR$250
- CAPLYTA$215
How this compares
$3,150 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $105,958 |
| VraylarCariprazine Hcl | 30 | $44,903 |
| SpravatoEsketamine Hcl | 21 | $25,049 |
| RexultiBrexpiprazole | 11 | $15,826 |
| Paliperidone ErPaliperidone | 19 | $2,740 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 24 | $2,569 |
| Vilazodone Hcl | 17 | $891 |
| Buspirone Hcl | 38 | $585 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $540 |
| Trazodone Hcl | 20 | $444 |
| Naltrexone Hcl | 11 | $411 |
| Hydroxyzine Hcl | 29 | $369 |
| Bupropion XlBupropion Hcl | 25 | $353 |
| Gabapentin | 32 | $305 |
| Hydroxyzine Pamoate | 26 | $283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $59 | $105,95813 claims |
| AbbVieVraylar | $1,067 | $44,90330 claims |
| Johnson & JohnsonSpravato | $48 | $25,04921 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $170 | $15,82611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Jeffersonville
- Paul DuncanJeffersonville$46K
- Anthony AemmerJeffersonville$9K
- Matthew CulbrethJeffersonville$7K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.